Our results confirm that apoptosis is a process that is being activated after the loss of function of RUNX2. Although RUNX2 has been reported to participate in the apoptotic process in other types of cancer, studies in lung cancer are scarce [7, 23–25]. This evidence concerns the gene RUNX2 and lung carcinoma.